Tomorrow I will make ~$70,000 in 8 hours.

  • #1
1,104
25
MY DRUG GOT APPROVED BY THE FDA AND IT IS THE FIRST DRUG OF ITS KIND!!!

http://biz.yahoo.com/bw/080520/20080520006603.html?.v=1


I've got at least 10,000 shares at $3.00. My stock should reach the $8-10 range tomorrow when the market opens. We've got a ton of other good crap in our pipeline, I could become filthy rich from just working here.
 

Answers and Replies

  • #2
794
1
MY DRUG GOT APPROVED BY THE FDA AND IT IS THE FIRST DRUG OF ITS KIND!!!

http://biz.yahoo.com/bw/080520/20080520006603.html?.v=1


I've got at least 10,000 shares at $3.00. My stock should reach the $8-10 range tomorrow when the market opens. We've got a ton of other good crap in our pipeline, I could become filthy rich from just working here.
Good--great---



--and, I'm glad you're not working on bad crap
 
  • #3
Math Is Hard
Staff Emeritus
Science Advisor
Gold Member
4,527
28
Congrats!
 
  • #4
500
0
That's exciting. I'm really happy because I might make 25,000 over the next 4 months...
 
  • #5
96
0
Is it really possible for the stock to increase 200% on just this one drug ? I mean is it really something many people are suffering from bowel reconstruction? If it were a cancer drug I would believe it but i guess we'll have to wait and see.
congrats on the windfall
 
  • #6
2,985
15
So, does this mean I should buy a whole bunch?

Are you sure you can announce this?
 
  • #7
1,482
3
Nice. You guys must have a good hunch or something.
 
  • #8
794
1
So, does this mean I should buy a whole bunch?

Are you sure you can announce this?
its a press announcement
 
  • #9
1,134
9
The press release is already posted, so its ok for him to mention it. By the way, good job!
 
  • #10
Evo
Mentor
23,172
2,914
Good luck GNW!
 
  • #11
Moonbear
Staff Emeritus
Science Advisor
Gold Member
11,490
52
Congrats! Though, I'm a bit confused. I thought that was the drug you were talking about a while ago that was running into major side effects in clinical trials and facing discontinuation. Or was it something similar in name/function, but not this one?
 
  • #12
18,354
8,145
16%+ in after market, looks like it will be a good day for you tomorrow! Next time tell us the day before the PR... JK! :)
 
Last edited:
  • #13
Moonbear
Staff Emeritus
Science Advisor
Gold Member
11,490
52
16%+ in after market, looks like it will be a good day for you tomorrow! Next time tell us the day before the PR... JK! :)
Should we start calling you Martha? :rofl:
 
  • #15
Astronuc
Staff Emeritus
Science Advisor
18,979
2,322
Congrats gnw. Don't go crazy spending it now. Certainly that could be useful for paying off school loans.

Hopefully this will boost the companies revenues and provide some breathing room for the near term.
 
  • #16
1,104
25
Congrats! Though, I'm a bit confused. I thought that was the drug you were talking about a while ago that was running into major side effects in clinical trials and facing discontinuation. Or was it something similar in name/function, but not this one?


Ha, it is the same drug indeed. So far, it is approved for short term use after post operative ileus surgery. The complications we have ran into were for long term usage of the drug to treat opioid bowel disfunction (OBD) which comes from the long term use of opioid analgesics for chronic pain. The FDA put a clinical hold against us for clinical trials in OBD, but after today the FDA lifted its hold and research will continue. This is why I think the stock will nearly double. The OBD market is much bigger and probably worth at least a billion dollars or more. If you look at the data from the last clinical trial for OBD all of the negative incidents came from only 1 research site. Why? Research will continue.


Right now we also have a 2 delta opioid agonists in phase II right now. The delta compounds are the first opioid pain killers out there to target the delta receptor. If that shows good data too, the sky is the limit since we have even more good stuff in our pipeline.

http://sec.edgar-online.com/2007/12/05/0001193125-07-259725/Section10.asp [Broken]





FYI---if you are not familiar with opioids, opioids are some of the most potent analgesics known. There are 3 main opioid receptors: mu, kappa, and delta. Drugs like morphine target the mu receptor. Our 2 compounds in phase II target the delta, which no drug out there right now does.
 
Last edited by a moderator:
  • #17
478
2
Congratulations! You work in Exton?
 
  • #19
Moonbear
Staff Emeritus
Science Advisor
Gold Member
11,490
52
Ha, it is the same drug indeed. So far, it is approved for short term use after post operative ileus surgery. The complications we have ran into were for long term usage of the drug to treat opioid bowel disfunction (OBD) which comes from the long term use of opioid analgesics for chronic pain. The FDA put a clinical hold against us for clinical trials in OBD, but after today the FDA lifted its hold and research will continue. This is why I think the stock will nearly double. The OBD market is much bigger and probably worth at least a billion dollars or more. If you look at the data from the last clinical trial for OBD all of the negative incidents came from only 1 research site. Why? Research will continue.


Right now we also have a 2 delta opioid agonists in phase II right now. The delta compounds are the first opioid pain killers out there to target the delta receptor. If that shows good data too, the sky is the limit since we have even more good stuff in our pipeline.

http://sec.edgar-online.com/2007/12/05/0001193125-07-259725/Section10.asp [Broken]





FYI---if you are not familiar with opioids, opioids are some of the most potent analgesics known. There are 3 main opioid receptors: mu, kappa, and delta. Drugs like morphine target the mu receptor. Our 2 compounds in phase II target the delta, which no drug out there right now does.
Ah, cool.

If you develop one specific for the kappa receptor, let me know! :biggrin: We're interested in that one in controlling reproductive cycles.
 
Last edited by a moderator:
  • #20
1,104
25
Ah, cool.

If you develop one specific for the kappa receptor, let me know! :biggrin: We're interested in that one in controlling reproductive cycles.
Actually you know what? I think we already have explored the kappa receptor. The program was started and axed before I even got there (for reasons I do not know). I'm sure if I look through our compound library I will find some potent kappa agonists/antagonists that we have previously made. The program could have been terminated due to toxicity issues or maybe for the simple fact that we didn't see any in vivo efficacy in pain models. But who knows, maybe they would work in another model for a different treatment.
 
  • #22
794
1
Looks like you'll have to wait a bit longer for that big reward gnw! :(
yep....


I had a feeling it wasn't going to be the big growth item like Viagra
 
  • #23
russ_watters
Mentor
20,126
6,644
Yeah.
Hey, I live in Collegeville (right near GSK). I'm working on a project in Exton right now - on Lancaster Ave.
 
  • #24
18,354
8,145
the market is just getting murdered lately. I am aching to get to the sidelines. I'm down 8% today.
 
  • #25
918
16
I had a feeling it wasn't going to be the big growth item like Viagra.
:rofl: Sorry, it didn't last more than 4 hours. You did well to get this at $3, it had been as high as $29 at one time.
 

Related Threads on Tomorrow I will make ~$70,000 in 8 hours.

  • Last Post
Replies
12
Views
1K
  • Last Post
Replies
15
Views
1K
  • Last Post
4
Replies
92
Views
9K
Replies
43
Views
8K
  • Last Post
Replies
7
Views
562
Replies
101
Views
81K
Replies
26
Views
3K
Replies
4
Views
2K
  • Last Post
Replies
13
Views
5K
Top